IXICO Announces Formation of US Operation in Chicago
London, England. For immediate release-May 11th, 2009
IXICO, Ltd., a global imaging technology and service company, announced today that it has opened its US operations in Chicago, Illinois. The new entity, formally known as IXICO US LLC, is owned in entirety by IXICO, Ltd., of London, England.
IXICO’s US office will provide business development and project management support to its expanding US customer base. The US office will also help facilitate IXICO’s planned expansion of its imaging center network and partnership alliance.
“We are very excited to extend our functional capabilities across the Atlantic, and Chicago provides a perfect central location to support our customers on both coasts,” said Derek Hill, Ph.D., IXICO’s founding CEO. “Chicago also provides a rich environment of imaging expertise at its local universities, as well as a pool of highly educated, well trained professionals in clinical trials project management.”
IXICO US will be managed by Ciaran Mark Cooper, Vice President US Business Development. “Our extended operational footprint is the perfect complement to our expanding business core,” said Cooper. “In addition to our full-service ICRO capabilities, we have recently released several new web-based image management tools that offer terrific value to our customers, both large and small. These tools can help optimize the communication and image management in the execution of imaging trials while providing significant time and cost savings to our clients. Our US expansion is a further indication of our growing business and continuing success.”
About IXICO
IXICO offers a full range of Imaging CRO services including comprehensive, technology-based solutions for the pharmaceutical, biotech and medical device industries across all therapeutic areas and clinical trial phases. IXICO recently released Trial Wire, its free, web-based image management tool. IXICO works within an ISO9001:2000 certified Quality Management System.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
